Annals of Translational Medicine, 5(10), 214.
Scotter, E.L., Abood, M.E. & Glass, M. (2010). The Endocannabinoid System as a Target for the
Treatment of Neurodegenerative Disease. British Journal of Pharmacology, 160(3), 480-498.
Shi, S., & Klotz, U. (2011). Age-Related Changes in Pharmacokinetics. Current Drug Metabolism, 12(7), 601-10.
Shohami, E., Cohen-Yeshurun, A., Magid, L., Algali, M. & Mechoulam, R. (2011). Endocannabinoids and Traumatic Brain Injury. British Journal of Pharmacology, 163(7), 1402-1410.
Singh G., Rees J.H. & Sander, J.W. (2007). Seizures and Epilepsy in Oncological Practice: Causes, Course, Mechanisms and Treatment. Journal of Neurology, Neurosurgery and Psychiatry, 78(4), 342–9.
Sizoo, E.M., Braam, L., Postma, T.J., Roeline, H., Pasman, W., Heimans…& Taphoorn, M.J.B. (2010). Symptoms and Problems in the End-of-life Phase of High Grade Glioma Patients.
Neuro-Oncology, 12(11), 1162-1166.
Sugiura, T. & Waku, K. (2000). 2-Arachidonoylglycerol and the Cannabinoid Receptors. Chemistry and Physics of Lipids, 108(1-2), 89-106.
Sulak, D., Saneto, R. & Goldstein, B. (February 28, 2017). Medical Marijuana for Seizures. Published on projectcbd.org. Retrieved from: https://www.projectcbd.org/article/medical-marijuana-seizures-sulak-saneto-goldstein
Theisen, Eloise. (2017). Cannabis for Seniors: Reducing Pharmaceuticals and Improving Quality of Life. Green Flower Media (www.learngreenflower.com). Original date of 2017 lecture unavailable. Retrieved from: https://www.learngreenflower.com/courses/63/Cannabis-For-Seniors-Reducing-Pharmaceuticals-and-Improving-Quality-of-Life
Torres, A., Linker, W., Land, D., & Gaudino, R. (2017). Study of Pesticides in Clones: Research Summary. Published by Steep Hill Labs, Inc., September 22. Retrieved from: https://landing.steephill.com/cleanclones
Tradounsky, G. (2013). Seizures in Palliative Care. Canadian Family Physician, 59(9), 951-955.
The United States of America As Represented by the Department of Health and Human Services, Original Assignee. Medicinal Acidic Cannabinoids. US patent 7807711 B2, issued January 27, 2011. Retrieved from: https://www.google.ch/patents/US7807711
Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D., Shainberg., A. & Sarne, Y. (2013). An Ultra-low Dose of Tetrahydrocannabinol Provides Cardioprotection. Biochemical Pharmacology, 85(11), 1626-33.
Wallace, M., Martin, B. & DeLorenzo, R.J. (2002). Evidence for a Physiological Role of Endocannabinoids in Modulation of Seizure Threshold and Severity. European Journal of Pharmacology, 452, 295-301.
World Health Organization Essential Medicines in Palliative Care, Executive Summary. (2013). Houston: International Association for Hospice and Palliative Care.
Zendulka, O., Dovrtelova, G., Noskova, K., Turjap, M., Sulcova, A., Hanus, L., & Jurica, J. (2016). Cannabinoids and Cytochrome P450 Interactions. Current Drug Metabolism, 17(3), 206-226.
REFERENCES-Difficult Road Of Dying